HALO - Financial Reports List - Halozyme Therapeutics, Inc. - IntrinsicAlpha

Halozyme Therapeutics, Inc. HALO

Healthcare - Biotechnology - NASDAQ - US

$ 59.35

-0.703 %

$ 7.33 B

Market Cap

17.3

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	29.55%	60.46%	73.70%
Annual Report	FY	10-K	2024-12-31	22.44%	57.71%	63.36%
Quarterly Report	Q3	8-K	2024-09-30	34.28%	67.42%	84.87%
Quarterly Report	Q2	8-K	2024-06-30	4.67%	24.74%	24.11%
Quarterly Report	Q1	8-K	2024-03-31	20.81%	93.92%	77.58%
Quarterly Report	Q4	8-K	2023-12-31	26.75%	47.98%	35.60%
Annual Report	FY	10-K	2023-12-31	25.62%	39.31%	26.18%
Quarterly Report	Q3	8-K	2023-09-30	3.38%	32.78%	5.99%
Quarterly Report	Q2	8-K	2023-06-30	45.07%	229.53%	177.33%
Quarterly Report	Q1	8-K	2023-03-31	38.25%	-34.09%	-28.90%

1